Here is your daily news to keep you well-informed:

Hospitals & Healthcare

• Better Ways Needed to Track Drug Safety: Report
• Not-For-Profit Hospitals Eye Continued Low Revenue Growth
• Patients leaving hospital against advice fare worse
• Seniors Undertreated for Asthma, and Many Skip Inhalers: Study
• Hepatitis C is a new worry for baby boomers, study shows

• FDA approves Protalix's Gaucher drug Elelyso
• AAFP Says No to 'Safe Use' Class of Drugs
• Pfizer settles lawsuit from BYU over Celebrex case

• Prescription pains: Woman charged for wrong medication
• CMS: ACA Drug Coverage Saving Seniors Billions

1. Better Ways Needed to Track Drug Safety: Report
   A management plan to gather, assess and respond to data about all medications' risks from the time they are approved until they are no longer on the market is needed to improve drug safety in the United States, says an Institute of Medicine report released Tuesday.
   HealthDay
   
   
2. Not-For-Profit Hospitals Eye Continued Low Revenue Growth
   If financial medians since 2009 are an accurate precursor, the nation's not-for-profit hospital sector can continue to expect low revenue growth on sluggish admissions in the current fiscal year, according to a report from Moody's Investors Service.
   HealthLeaders Media
   
   
3. Patients leaving hospital against advice fare worse
   Hospital patients who leave against medical advice may have an increased risk of being readmitted or dying within a month, a study at one New York medical center finds.
   Reuters
   
   
4. Seniors Undertreated for Asthma, and Many Skip Inhalers: Study
   Asthma often is misdiagnosed and undertreated in older people, with only 53 percent of those with asthma using prescribed inhalers, a small new study suggests.
   HealthDay
   
   

---



---

5. Hepatitis C is a new worry for baby boomers, study shows
   The number of baby boomers dying from a "silent epidemic" of hepatitis C infections is increasing so rapidly that federal officials are planning a new nationwide push for widespread testing.
   Boston Herald
   
   

1. FDA approves Protalix's Gaucher drug Elelyso
   The Food and Drug Administration on Tuesday approved a new treatment for Gaucher disease, a rare genetic disorder that can cause liver and neurological problems.
   Business Week
   
   
2. AAFP Says No to 'Safe Use' Class of Drugs
   The American Academy of Family Physicians (AAFP) has voiced its opposition to an FDA proposal that would allow pharmacists to dispense some drugs without a prescription.
   MedPage Today
   
   
3. Pfizer settles lawsuit from BYU over Celebrex case
   Pfizer Inc. has announced the settlement of a multi-billion-dollar lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex.
   Associated Press
   
   

1. Prescription pains: Woman charged for wrong medication
   Ingrid Allen says CVS Pharmacy filled the wrong prescription, but still charged her. Now, Allen is out $218.
   KENS 5 News
   
   
2. CMS: ACA Drug Coverage Saving Seniors Billions
   A provision in the Affordable Care Act (ACA) that closes the so-called doughnut hole in Medicare Part D has saved beneficiaries $3.4 billion on prescription drugs, according to the Centers for Medicare and Medicaid Services (CMS).
   MedPage Today
   
   

PharmacyOneSource.com Privacy Policy
Pharmacy OneSource, 7780 Elmwood Ave. Ste #210 Middleton, WI 53562
Phone: (800) 654-8395